Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2008
This randomized phase II trial is studying palifermin to see how well it works compared with a placebo in preventing oral mucositis caused by chemotherapy and/or radiation therapy in young patients undergoing stem cell transplant. Palifermin may help relieve or prevent oral mucositis caused by chemotherapy and radiation therapy in young patients undergoing stem cell transplant.
Epistemonikos ID: 3ab08c63b5deb3c3562ec24ceeabc6ccf6eaad2d
First added on: Jan 21, 2022